Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy.
Kobayashi
I
I
Nakanishi
M
M
Okano
M
M
Sakiyama
Y
Y
Matsumoto
S
S
D001327:Autoimmune Diseases / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D001623:Betamethasone / Q000008:administration & dosage* / Q000009:adverse effects; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D008040:Genetic Linkage / Q000235:genetics; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007223:Infant; D007410:Intestinal Diseases / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D008297:Male; D012729:Sex Chromosome Aberrations / Q000235:genetics*; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects; D014960:X Chromosome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001623:Betamethasone; D016559:Tacrolimus